Initial treatment comprised prednisone 5 mg t.d.s. and amitriptyline 25 mg daily. He spent the whole of the next day in the dayroom and ate a light diet. After a week the dose of amitriptyline was increased to 50 mg daily. He steadily improved. After 2 weeks he was fully mobile, no longer depressed and eating normally. He required a course of antibiotics for a troublesome cough productive of green sputum. After 4 weeks he suddenly became confused and died less than an hour later.
Our experience suggests that prednisone should be prescribed in all cases of moderate or severe generalized weakness associated with terminal lung cancer. The usual dose is 5 mg t.d.s. More often than not it helps and sometimes the effect is dramatic, as in the above case. It is probable that, in the majority of cases, the weakness is caused by hypercalcaemia induced by the malignant process. An elevated plasma ionized calcium concentration in cancer can lead to a wide variety of symptoms, including pain of a diffuse nature, nausea and vomiting, generalized weakness, tiredness, lassitude, drowsiness and other mental symptoms. 15-20% of all cancer patients develop hypercalcaemia at some stage of their illness and in breast and lung cancer the percentage is even higher than this overall figure (Watson, 1966) . Unfortunately, in the presence of hypoalbuminaemia the total plasma calcium concentration may remain normal despite a definite elevation in the ionized calcium level. Consequently, it is necessary to act on a high level of clinical suspicion rather than rely on biochemical estimation. Both cortisone acetate and prednisone will correct the majority of hypercalcaemic states associated with malignant disease.
Rightly or wrongly we do not screen patients routinely for biochemical abnormalities. Perhaps we ought, as we should then be able to exclude patients in whom glucocorticosteroid therapy might make matters worse. Recently, a 72-year-old man with lung cancer was admitted with severe, incapacitating weakness. On account of previously diagnosed hypopituitarism he had been receiving cortisone acetate 50 mg daily for 5 years. His serum potassium concentration was 2-4 mEq/l. He improved when prescribed effervescent potassium chloride 1 g t.d.s. and after 10 days his serum potassium had risen to 3-7 mEq/l. His improvement, however, was shortlived and after this he began to deteriorate and died a few days later.
Pain
Pain experienced by terminal cancer patients may be due to a variety of causes (Table 2) . Pain due to Patients in pain require analgesia. Most doctors would agree that simple analgesics should be tried in the first instance. The right dose of any analgesic is that which gives adequate relief for a reasonable period of time. Patients do not want to be constantly swallowing tablets or receiving injections. A 4 hour interval between doses should be regarded as the norm, though, on occasion, a shorter interval may be necessary. The abbreviation 'p.r.n.' has little or no place in the treatment of cancer pain: chronic pain, whatever the aetiology, requires regular preventive therapy. Once a drug has been shown to be ineffective the patient should be transferred to an alternative. Eventually the alternative will be a narcotic analgesic such as dipipanone, methadone or phenazocine.
When and if the pain becomes so severe that synthetic narcotic analgesics fail to provide adequate relief, one should not hesitate to turn to morphine or diamorphine. Many doctors fear both these preparations. I would suggest that in the situation we are discussing, this fear is entirely unjustified. Bogeys of addiction and escalating dosage often result in the statement, 'I think we ought to save the morphine until things get really bad'. Such statements to a relative can be guaranteed to do just that-intensify the pain in the patient-but still the morphine is not forthcoming. When other drugs have failed I would suggest a doctor is failing in his duty if he does not prescribe morphine or diamorphine.
At An apical lung cancer (Pancoast tumour) is liable to invade not only adjacent bone but also the nerves of the brachial plexus. Whereas involvement of the first or second rib gives rise to local pain, involvement of the brachial plexus produces sensory or motor disturbances in the arm, and involvement of the sympathetic nerve chain results in an ipsilateral Horner's syndrome. The pain felt in the arm is incessant with periodic short sharp exacerbations. The sensible use of drugs will dull the pain considerably though the exacerbations usually defy pharmacological control. Two patients admitted recently with this syndrome both died within 48 hr. One deteriorated so rapidly that further assessment was impossible: the other was greatly helped by a combination of diamorphine 10 mg and chlorpromazine 50 mg 4 hourly. After sleeping soundly the second night he woke up refreshed and relaxed, but died suddenly an hour or two later. Most patients with Pancoast's syndrome will, however, probably be referred at a somewhat earlier stage to a Pain Clinic where, if analgesics prove inadequate, a phenol nerve block or transcutaneous tractotomy may be recommended.
Dyspnoea and cough
These usually go together. As with pain, anxiety and fear greatly potentiate the distress that accompanies severe dyspnoea. He was re-admitted 6 weeks later on account of increasing dyspnoea due to pneumonia; his antibiotic was changed to oxytetracycline and diamorphine reintroduced. After 3 weeks, in July 1972, he returned home still on diamorphine. In September he was re-admitted generally less well. He developed troublesome bone secondaries, spent more and more time in bed and began to have periods of confusion. He was, however, kept comfortable by the continued use of diamorphine. He died towards the end of October 1972.
Anorexia and weight loss
Both are common in terminal lung cancer patients. It is easier to correct anorexia than weight loss. Appetite often improves simply by admitting a patient to hospital-especially in the elderly or a person living alone. Some note improvement when symptoms such as nausea and pain are controlled. In others, where the anorexia is a manifestation of depression, treatment with, for example, amitriptyline causes a return of appetite. When all else fails it is worth trying prednisone 5-10 mg t.d.s. for up to 2 weeks. If effective it can be continued, otherwise, it should be stopped. Some patients receiving chlorpromazine or a glucocorticosteroid become hyperphagic. This is usually welcomed by the patient although, occasionally, modification of the patient's drug regimen is necessary. Weight loss in association with malignant disease is not solely the result of anorexia. Consequently, a return of appetite does not mean that weight loss will be corrected or even halted. Nausea and vomiting
There was no significant difference between those patients who had received radiotherapy and those who had not in relation to nausea and vomiting. Both nausea and vomiting are usually relieved either by a phenothiazine, metoclopramide (Maxolon) or cyclizine.
Haemoptysis
When the haemoptysis is little more than bloodstained sputum, reassurance is usually all that is necessary. Frank haemoptysis can be controlled by prednisone or radiotherapy. Massive haemoptysis requires sedation with an intramuscular opiate and a nurse to hold the patient's hand. Very rarely, the massive haemoptysis is best described as 'catastrophic haemorrhage'. This results from erosion of the aortic arch or one of its main branches. There is no treatment: the patient dies immediately.
Miscellaneous
Hoarseness due to left recurrent laryngeal nerve palsy is untreatable but reassurance that the voice will not fade away entirely is usually welcomed by the patient. Superior vena caval obstruction, when it occurs, varies in intensity. It usually responds to treatment with a diuretic and prednisone. If these do not help radiotherapy should be considered. Fractured femurs and paraplegia occur from time to time. Provided the patient is reasonably well in himself, pinning of the femur should be considered. Incipient paraplegia due to vertebral erosion and collapse can often be arrested by irradiating the involved vertebral body.
Patients who have had thoracic surgery, i.e. lobectomy or pneumectomy, have a greater incidence of cerebral secondaries compared with those who have not. On the other hand, in patients who have not had surgery there is a greater incidence of haemoptysis, pain, anorexia and weight loss. The mode of death of those patients is summari7ed in Table 4 . Massive haemoptysis and catastrophic haemorrhage are both rare.
Conclusion
Terminal care does not, however, stop at the drug trolley. Sir David Smithers recently said that no-one who hasn't time for chat knows anything about DR SCADDING: In your patient who recurred after 11 years, was it the same histology or was it a new primary? DR TWYCROSS (St Christopher's Hospice): I meant to say it could well have been a second primary. It is interesting to note that in those 2 years I was only able to put up 185 patients to take those symptoms from. There were eight other patients but they had to be excluded because they all had associated other primary carcinomas and I think that with a common disease such as lung cancer the possibility of a second lung cancer cannot be excluded.
Dr K. P. BALL (Central Middlesex Hospital): I was very interested to hear you comment about the importance of chat. I remember Dr Arthur Wilox, a physician that many of us will remember from the Middlesex, used to underline the importance of not hurrying past a dying patient's bed. It is very easy to do it on a busy round when one has other people to see for whom one could think you can do more. Another problem, of course, is that there are not enough St Christopher's Hospices about. Many of the kinds of things you have been recommending there are difficult to do in a general hospital. Obviously we ought to apply many more things in our own wards but we cannot do all of them.
DR TwYcRoss: I accept there are problems, and I hope I made it clear that I fully understood it, having worked in general hospitals for some time before I took up this research fellowship. I do not know what the answer is except to follow the advice of the physician you referred to, and that of Sir David Smithers. I think it must be difficult for someone who is under the care of a radiotherapist or a chest physician who has been working trying to cure them and then suddenly at some time you have got to face up to the reality that you have failed. Gloom and everything goes rapidly across, not only the medical team but the relatives and the patient. I don't know whether it is possible to get round this. We start afresh because we take them on and we have a fresh approach. We don't have a legacy of failure and we don't look at these patients as having incurable cancer. We tend to think of them as having diseases of pain, weakeness, anorexia, etc. We set out to treat those, and when you have clerked a patient we say 'Well, look. Your problem seems to me (1) you have got pain, (2) you
